Physician profile
Darry S Johnson
NPI 1326088428
$297,268.13
in general payments reported to CMS, 2019-2025
74 companies · $16K in 2025
The $16K reported for 2025 was more than what 92% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $59K · 2021: $84K · 2022: $62K · 2023: $23K · 2024: $14K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Food and Beverage: $18K · Consulting Fee: $3,625 · Travel and Lodging: $438 · Education: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,300.00 |
| Food and Beverage | $18,076.62 |
| Consulting Fee | $3,625.00 |
| Travel and Lodging | $437.96 |
| Education | $254.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $91,897.18 | 2019-2025 | Reyvow, Emgality, Kisunla |
| Abbvie INC. | $68,289.34 | 2020-2025 | |
| Biohaven Pharmaceuticals, INC. | $39,433.80 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $32,892.92 | 2019-2025 | Ajovy, Austedo Xr, Austedo |
| Biohaven Pharmaceutical Holding Company LTD. | $19,427.83 | 2022 | |
| Allergan, INC. | $9,224.42 | 2020-2022 | |
| Promius Pharma LLC | $4,848.06 | 2019 | |
| Avanir Pharmaceuticals, INC. | $4,790.24 | 2019-2022 | |
| Argenx US, INC. | $4,480.04 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Ucb, INC. | $2,999.01 | 2020-2025 | Briviact, Rystiggo, Fintepla |
| Supernus Pharmaceuticals, INC. | $1,595.23 | 2020-2022 | |
| Amneal Pharmaceuticals LLC | $1,560.55 | 2020-2025 | Rytary, Crexont, Lyvispah |
| Biogen, INC. | $1,390.26 | 2020-2025 | Vumerity, Tysabri, Spinraza |
| Alexion Pharmaceuticals, INC. | $1,386.31 | 2020-2025 | Ultomiris |
| Sk Life Science, INC. | $1,208.68 | 2020-2025 | Xcopri |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,084.67 | 2020-2025 | |
| Acadia Pharmaceuticals INC | $1,041.62 | 2020-2025 | Nuplazid |
| Lundbeck LLC | $1,037.87 | 2020-2025 | Rexulti, Vyepti |
| Genentech USA, INC. | $712.57 | 2020-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Emd Serono, INC. | $699.92 | 2020-2025 | Mavenclad, Mavenclad |
| Pfizer INC. | $611.29 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $603.32 | 2023-2025 | Nuedexta, Rexulti |
| Neurocrine Biosciences, INC. | $592.32 | 2020-2025 | Ingrezza, Ongentys |
| Neurelis, INC. | $524.41 | 2020-2025 | Valtoco |
| Eisai INC. | $459.35 | 2023-2025 | |
| Amgen INC. | $397.16 | 2020-2025 | Uplizna |
| Upsher-Smith Laboratories LLC | $367.15 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $299.74 | 2020-2025 | Acthar |
| Merz Pharmaceuticals, LLC | $248.36 | 2023-2025 | Xeomin, Inbrija |
| Grifols USA, LLC | $225.14 | 2022-2025 | Gamunex-C |
| Celgene Corporation | $199.96 | 2021-2024 | Zeposia |
| Scilex Pharmaceuticals INC. | $173.34 | 2023-2024 | Ztlido |
| Genzyme Corporation | $168.87 | 2022-2025 | |
| Harmony Biosciences LLC | $165.88 | 2020-2024 | Wakix |
| Mdd US Operations, LLC | $154.18 | 2019-2023 | Apokyn |
| Acorda Therapeutics, INC | $152.33 | 2020-2024 | Ampyra |
| Kyowa Kirin, INC. | $150.43 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $145.15 | 2021-2023 | Ponvory |
| Tanabe Pharma America, INC. | $141.47 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $138.16 | 2023-2024 | Aptiom |
| Ge Healthcare | $115.99 | 2023-2025 | |
| Medtronic, INC. | $114.37 | 2025 | Sensight |
| Corium, LLC | $106.42 | 2022-2023 | Adlarity |
| Horizon Therapeutics Plc | $103.87 | 2021-2023 | Uplizna |
| E.R. Squibb & Sons, L.L.C. | $79.82 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $58.23 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $58.06 | 2022 | |
| Impel Pharmaceuticals LLC | $55.44 | 2025 | Trudhesa |
| Banner Life Sciences, LLC | $50.49 | 2021-2022 | |
| Genentech, INC. | $49.95 | 2021 | |
| Almatica Pharma LLC | $48.32 | 2021 | |
| Jazz Pharmaceuticals INC. | $46.20 | 2022-2024 | |
| Abbott Laboratories | $41.72 | 2021-2022 | |
| Impel Pharmaceuticals INC. | $36.06 | 2023 | Trudhesa |
| Alnylam Pharmaceuticals INC. | $32.61 | 2023 | Amvuttra |
| Nevro Corp. | $28.88 | 2022 | |
| Currax Pharmaceuticals LLC | $28.81 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $26.27 | 2022 | |
| Novo Nordisk INC | $25.83 | 2020 | |
| Livanova USA, INC. | $25.60 | 2022 | |
| Tg Therapeutics, INC. | $20.78 | 2023 | |
| Orthofix Medical, INC. | $19.51 | 2020-2021 | |
| Merz North America, INC. | $19.29 | 2020 | |
| Arbor Pharmaceuticals, INC. | $17.56 | 2020 | |
| Janssen Biotech, INC. | $16.77 | 2025 | |
| Tonix Medicines, INC. | $14.41 | 2025 | Zembrace Symtouch |
| Axsome Therapeutics, INC. | $14.40 | 2025 | Auvelity |
| Xeris Pharmaceuticals, INC. | $14.37 | 2022 | |
| Cala Health, INC. | $14.32 | 2023 | Cala Trio |
| Otto Bock Healthcare LP | $14.19 | 2021 | |
| Azurity Pharmaceuticals, INC. | $13.70 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $13.24 | 2021 | |
| Bausch Health US, LLC | $12.49 | 2022 | |
| Assertio Therapeutics, INC. | $11.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darry Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.